Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Vanderwaltozyma polyspora Nuclear rim protein 1 (NUR1), partial CSB-YP416574VDW1
CSB-EP416574VDW1
CSB-BP416574VDW1
CSB-MP416574VDW1
CSB-EP416574VDW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Transcriptional acticator POG1 (POG1) CSB-YP416575VDW
CSB-EP416575VDW
CSB-BP416575VDW
CSB-MP416575VDW
CSB-EP416575VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Ribosome biogenesis protein ALB1 (ALB1) CSB-YP416576VDW
CSB-EP416576VDW
CSB-BP416576VDW
CSB-MP416576VDW
CSB-EP416576VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Required for respiratory growth protein 9, mitochondrial (RRG9) CSB-YP416577VDW
CSB-EP416577VDW
CSB-BP416577VDW
CSB-MP416577VDW
CSB-EP416577VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Autophagy-related protein 16 (ATG16) CSB-YP416578VDW
CSB-EP416578VDW
CSB-BP416578VDW
CSB-MP416578VDW
CSB-EP416578VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Serine/threonine-protein kinase atg1 (ATG1), partial CSB-YP416579VDW
CSB-EP416579VDW
CSB-BP416579VDW
CSB-MP416579VDW
CSB-EP416579VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Putative DNA helicase INO80 (INO80), partial CSB-YP416580VDW
CSB-EP416580VDW
CSB-BP416580VDW
CSB-MP416580VDW
CSB-EP416580VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora U1 small nuclear ribonucleoprotein component SNU71 (SNU71), partial CSB-YP416581VDW
CSB-EP416581VDW
CSB-BP416581VDW
CSB-MP416581VDW
CSB-EP416581VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora WD repeat-containing protein Kpol_530p43 (Kpol_530p43), partial CSB-YP416582VDW
CSB-EP416582VDW
CSB-BP416582VDW
CSB-MP416582VDW
CSB-EP416582VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Phosphatidylethanolamine N-methyltransferase 2 (CHO2-2), partial CSB-YP416583VDW
CSB-EP416583VDW
CSB-BP416583VDW
CSB-MP416583VDW
CSB-EP416583VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Probable zinc metalloprotease Kpol_1052p9 (Kpol_1052p9), partial CSB-YP416584VDW
CSB-EP416584VDW
CSB-BP416584VDW
CSB-MP416584VDW
CSB-EP416584VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Autophagy-related protein 23 (ATG23) CSB-YP416585VDW
CSB-EP416585VDW
CSB-BP416585VDW
CSB-MP416585VDW
CSB-EP416585VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora rRNA-processing protein EFG1 (EFG1) CSB-YP416586VDW
CSB-EP416586VDW
CSB-BP416586VDW
CSB-MP416586VDW
CSB-EP416586VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Altered inheritance of mitochondria protein 37, mitochondrial (AIM37) CSB-YP416587VDW
CSB-EP416587VDW
CSB-BP416587VDW
CSB-MP416587VDW
CSB-EP416587VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Restriction of telomere capping protein 5 (RTC5), partial CSB-YP416588VDW
CSB-EP416588VDW
CSB-BP416588VDW
CSB-MP416588VDW
CSB-EP416588VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Altered inheritance of mitochondria protein 39, mitochondrial (AIM39), partial CSB-YP416589VDW1
CSB-EP416589VDW1
CSB-BP416589VDW1
CSB-MP416589VDW1
CSB-EP416589VDW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Potential protein lysine methyltransferase SET5 (SET5) CSB-YP416590VDW
CSB-EP416590VDW
CSB-BP416590VDW
CSB-MP416590VDW
CSB-EP416590VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Ubiquitin-related modifier 1 (URM1) CSB-YP416591VDW
CSB-EP416591VDW
CSB-BP416591VDW
CSB-MP416591VDW
CSB-EP416591VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Glucose starvation modulator protein 1 (GSM1) CSB-YP416592VDW
CSB-EP416592VDW
CSB-BP416592VDW
CSB-MP416592VDW
CSB-EP416592VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vanderwaltozyma polyspora Sensitivity to high expression protein 10 (SHE10), partial CSB-YP416593VDW
CSB-EP416593VDW
CSB-BP416593VDW
CSB-MP416593VDW
CSB-EP416593VDW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>